Using a new pathway to manage unexplained pain in children with severe neurological impairments
Official title: Implementation of the Pain and Irritability of Unknown Origin (PIUO) Pathway in Community Pediatric Practices
Run by University of British Columbia · NCT06869928 · Data updated 2026-11-12
This study is testing a new way for doctors to help manage unexplained pain in children with severe neurological impairments who can't tell us how they feel.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Months to 18 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | June 28, 2024 |
| Main results expected | March 2026 |
| Study ends | May 2026 |
| Registry record updated | March 11, 2025 |
| Trial ID | NCT06869928 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 6 months to 18 years with severe neurological impairments who experience unexplained pain and irritability and cannot communicate their pain.
✕Probably not a fit
Patients who can localize their pain or have a known and treatable cause of pain will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study implements the Pain and Irritability of Unknown Origin (PIUO) Pathway in community pediatric practices to evaluate and manage unexplained pain and irritability in children with severe neurological impairments who cannot communicate their pain. The pathway, previously used in specialized hospital settings, aims to train community pediatricians in British Columbia to effectively utilize this tool. By enhancing the clinical care for these vulnerable children, the study seeks to create a systematic approach to pain management that can be sustained in community settings. The research will assess the feasibility and effectiveness of this implementation.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and quality of life for children with severe neurological impairments.
How similar studies have gone: While the PIUO Pathway has been effective in specialized settings, this implementation in community practices is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Pain Pathway Intervention Inclusion Criteria: * Children aged 6 months to 18 years with SNI (from any cause) with unexplained pain and irritability and whose cognitive or communication impairments prevent determination of pain location, cause, and type will be eligible to participate. * Eligible children will have cognitive impairment or be non-verbal. Parents should have sufficient English skills, or have access to assistance, to participate in the clinic visits and complete survey tools. Pain Pathway Intervention Exclusion Criteria: * Children not within the specified age range * Children with communication capabilities and cognitive development to localize their pain * Children that have an explained and treatable cause of pain and irritability. Parents that do not have sufficient English skills, or have access to assistance, to participate in the clinic visits and complete survey tools. Implementation Participant Inclusion Criteria: * General pediatricians * Practicing in a community clinic in British Columbia Implementation Participant Exclusion Criteria: \- Healthcare professionals who are not general pediatricians (e.g., pediatrician specialists, nurse practitioners, nurses, other allied health professionals)
Where it's running
-
BC Children's Hospital
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Hal Siden, MD — University of British Columbia and BC Children's Hospital Research Institute
- Study coordinator: Sharon Hou, PhD
- Email: sharon.hou@bcchr.ca
- Phone: 604-875-2345
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Grappling with Trauma: BJJ for First Responders
This program tests whether eight weeks of Brazilian Jiu-Jitsu can be tied to changes in trauma-related symptoms for first responders who prefer movement-based activities over traditional mental health services.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.